Europe Genome Engineering Market was valued at USD 2.2 Billion in 2022 and is projected to reach USD 7 Billion by 2030, growing at a CAGR of 15% from 2024 to 2030.
The European Genome Engineering market is evolving rapidly, driven by significant advancements in genetic modification technologies and increasing demand across multiple industries. The scope of this market extends from agriculture to healthcare, with biotechnology being a major contributor to the growth. As the need for more efficient and precise genome editing tools escalates, European industries are increasingly adopting CRISPR and other genome engineering technologies for a variety of applications, from drug development to agriculture improvement. But what is driving this change?
In Europe, industries are seeking new methods to address complex challenges such as genetic diseases, food security, and sustainable energy. Genome engineering has opened doors to solutions that were previously unimaginable. For example, in the healthcare sector, the precision offered by genome editing allows for the creation of customized gene therapies, paving the way for personalized medicine. Furthermore, the agriculture sector is leveraging these technologies to produce more resilient crops and to reduce the dependency on harmful pesticides and fertilizers, thus promoting sustainable farming.
One of the key driving forces behind the growth of the European Genome Engineering market is the rising demand from pharmaceutical companies for gene therapies. These companies are constantly seeking to develop more targeted treatments for genetic disorders. Additionally, the increasing acceptance of genetically modified organisms (GMOs) in Europe is encouraging agricultural and food industries to explore genome engineering to enhance crop yield, resistance to pests, and overall nutritional value.
Another important requirement coming from European industries is the need for advanced tools that allow for high precision, efficiency, and scalability. As the regulatory landscape continues to evolve, industries require genome engineering solutions that not only comply with European laws but also ensure safety and ethics in their applications. The demand for such technologies is expected to surge, particularly in the pharmaceutical and agricultural sectors, which are eager to benefit from the benefits of genome engineering technologies.
The European Genome Engineering market is poised to expand significantly as both industries and research institutions push for new breakthroughs. The market's growth reflects the increasing need for innovative tools to address complex biological challenges, and as such, the market is projected to witness continued investment and development in the coming years.
Get an In-Depth Research Analysis of the Europe Genome Engineering Market Size And Forecast [2025-2032]
Â
Thermo Fisher Scientific
Merck KGaA
Horizon Discovery
Genscript USA
Sangamo Biosciences
Integrated DNA Technologies
Origene Technologies
Transposagen Biopharmaceuticals
Lonza Group
New England Biolabs
Â
By the year 2030, the scale for growth in the market research industry is reported to be above 120 billion which further indicates its projected compound annual growth rate (CAGR), of more than 5.8% from 2023 to 2030. There have also been disruptions in the industry due to advancements in machine learning, artificial intelligence and data analytics There is predictive analysis and real time information about consumers which such technologies provide to the companies enabling them to make better and precise decisions. The Asia-Pacific region is expected to be a key driver of growth, accounting for more than 35% of total revenue growth. In addition, new innovative techniques such as mobile surveys, social listening, and online panels, which emphasize speed, precision, and customization, are also transforming this particular sector.
Get Discount On The Purchase of the Europe Genome Engineering Market Size And Forecast [2025-2032]
Growing demand for below applications around the world has had a direct impact on the growth of the Europe Genome Engineering Market
CRISPR/Cas9
Zinc Finger Nucleases (ZFNs)
Transcription Activator-Like Effector Nucleases (TALENs)
RNA Interference (RNAi)
Base Editing
Biomedical Research
Genetic Engineering in Agriculture
Therapeutic Development
Animal Model Development
Industrial Biotechnology
Academic Research Institutes
Biotechnology Companies
Pharmaceutical Companies
Food & Agriculture Companies
Government Research Organizations
Gene Editing
Gene Analysis
Gene Delivery
Data Analysis
Quality Control
Kits & Reagents
Instruments & Devices
Services
Software Solutions
Consumables
US (United States, US and Mexico)
Europe (Germany, UK, France, Italy, Russia, Turkey, etc.)
Asia-Pacific (China, Japan, Korea, India, Australia, Indonesia, Thailand, Philippines, Malaysia and Vietnam)
South America (Brazil, Argentina, Columbia, etc.)
Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)
For More Information or Query, Visit @ Genome Engineering Market Research Analysis
1. Introduction of the Europe Genome Engineering Market
Overview of the Market
Scope of Report
Assumptions
2. Executive Summary
3. Research Methodology of Verified Market Reports
Data Mining
Validation
Primary Interviews
List of Data Sources
4. Europe Genome Engineering Market Outlook
Overview
Market Dynamics
Drivers
Restraints
Opportunities
Porters Five Force Model
Value Chain Analysis
5. Europe Genome Engineering Market, By Type
6. Europe Genome Engineering Market, By Application
7. Europe Genome Engineering Market, By Geography
US
Europe
Asia Pacific
Rest of the World
8. Europe Genome Engineering Market Competitive Landscape
Overview
Company Market Ranking
Key Development Strategies
9. Company Profiles
10. Appendix
About Us: Verified Market Reports
Verified Market Reports is a leading Europe Research and Consulting firm servicing over 5000+ US clients. We provide advanced analytical research solutions while offering information-enriched research studies. We also offer insights into strategic and growth analyses and data necessary to achieve corporate goals and critical revenue decisions.
Our 250 Analysts and SMEs offer a high level of expertise in data collection and governance using industrial techniques to collect and analyze data on more than 25,000 high-impact and niche markets. Our analysts are trained to combine modern data collection techniques, superior research methodology, expertise, and years of collective experience to produce informative and accurate research.
Contact us:
Mr. Edwyne Fernandes
US: +1 (650)-781-4080
US Toll-Free: +1 (800)-782-1768
Website: https://www.verifiedmarketreports.com/